Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02354131 |
| Title | Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (AVANOVA) |
| Acronym | AVANOVA |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Nordic Society for Gynaecologic Oncology |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | DNK |